Bacteriostatic Sodium Chloride Injection
Product Images NDC 63323-924

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bacteriostatic Sodium Chloride (NDC 63323-924). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Bac0a 0000 01)

FDA Label Image

924830-vial (Bac0a 0000 02)

924830-vial (Bac0a 0000 02)
This is a 30mL multiple dose vial of Bacteriostatic Sodium Chloride Injection, USP with NDC 63323-924-03 and lot number 924830. It is meant for drug diluent use only and should not be used for inhalation or in newborns. It contains L 0.9% sodium chloride.*
FDA Label Image

Package Label – Principal Display (Bacteriostatic Sodium Chloride 30 mL Multiple Dose Vial Tray Label)

Package Label – Principal Display (Bacteriostatic Sodium Chloride 30 mL Multiple Dose Vial Tray Label)
This text is a description of a BACTERIOSTATIC Sterile and Nonpyrogenic injection of SODIUM CHLORIDE. The Usual Dosage, storage temperature, and package insert information is also provided. The injection contains 9mg of Sodium chloride and 0.9% of benzyl alcohol. It is not recommended for use in newborns or for inhalation. The injection is suitable for drug diluent use only. The pH may be adjusted using HCI and/or NaOH. The manufacturer is Fresenius Kabi, located in Lake Zurich, IL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.